summary
Introduced
01/05/2026
01/05/2026
In Committee
02/19/2026
02/19/2026
Crossed Over
01/29/2026
01/29/2026
Passed
03/03/2026
03/03/2026
Dead
Signed/Enacted/Adopted
03/03/2026
03/03/2026
Introduced Session
2026 Regular Session
Bill Summary
Coverage for certain cancer prescriptions. Prohibits a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization that provides coverage for advanced, metastatic cancer and associated conditions from requiring that, before providing coverage for a prescription drug, the insured fail to successfully respond to a different prescription drug or prove a history of failure of a different prescription drug.
AI Summary
This bill, effective July 1, 2026, prohibits state employee health plans, accident and sickness insurance policies, and health maintenance organizations (HMOs) from requiring individuals to first fail or prove failure of a different prescription drug before covering a new one for advanced, metastatic cancer or its associated conditions, provided the drug is consistent with best practices, supported by evidence, and approved by the FDA. "Advanced, metastatic cancer" is defined as cancer that has spread from its original site, and "associated conditions" are symptoms or side effects directly related to the cancer or its treatment that would worsen the patient's health if left untreated, as recommended by a healthcare practitioner and supported by clinical evidence.
Committee Categories
Budget and Finance, Business and Industry
Sponsors (9)
Cherrish Pryor (D)*,
Vaneta Becker (R),
Martin Carbaugh (R),
Lori Goss-Reaves (R),
Fady Qaddoura (D),
Lonnie Randolph (D),
Robin Shackleford (D),
Greg Taylor (D),
Kyle Walker (R),
Last Action
Signed by the Governor (on 03/03/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...